Active market:United States
Treatment Cost Guides
These first cost pages are built for US treatment intent and only use structured, reviewed content. They are meant to help users evaluate pricing friction, insurance realities, and the safest next step before entering a provider flow.
Validation Note
These pages summarize official savings and regulatory sources, but real out-of-pocket cost still depends on brand, dose, insurance design, prescribing path, and pharmacy fulfillment.
Semaglutide
Semaglutide Cost Guide: Wegovy, Ozempic, Coverage and Savings
In the United States, semaglutide costs depend on brand, indication, dose, insurance design, and whether the prescription is filled through an official self-pay or savings pathway.
Coverage: Commercial coverage varies widely. Type 2 diabetes coverage does not automatically mean obesity coverage, and weight-management prescriptions often face stricter formulary and prior-authorization rules.
Savings: Official manufacturer savings programs may reduce out-of-pocket cost for eligible commercially insured patients, and some self-pay introductory offers are available through official fulfillment channels.
Tirzepatide
Tirzepatide Cost Guide: Zepbound, Mounjaro, Coverage and Savings
In the United States, tirzepatide costs depend on whether the prescription is routed through Zepbound or Mounjaro pathways, the indication, the dose, and whether you qualify for official coverage or self-pay offers.
Coverage: Coverage remains highly plan-dependent. Weight-management access often differs from diabetes coverage, and approved use does not guarantee a simple covered pathway.
Savings: Official Zepbound savings options may reduce cost for eligible patients with commercial coverage, and Lilly also publishes self-pay program terms for certain presentations.
This content is for informational purposes only and does not constitute medical advice.